Programme

Wednesday, September 23, 2026

• 08:00–09:00 Morning Abstract and Concurrent Sessions
  View Session Details

• 08:00–09:00 Metabolic dysfunction and liver transplantation
  Room C4.1 Concurrent Liver/Intestine

  View Session Details

  Getting the right patients to transplant: Patient selection, pre-transplant evaluation, and organ allocation in MAFLD

  Kymberly Watt (US)

  Optimising outcomes in patients with obesity after transplant: lifestyle modification, bariatric surgery or lifelong GLP1 therapy?

  Marina Berenguer (ES)
• 08:00–09:00 Key components of an ideal high volume transplant program setup: A global surgical perspective
  Room C3.6 Concurrent Surgery

  View Session Details

  The European perspective

  Jiri Fronek (CZ)

  The Oceania perspective

  Henry Pleass (AU)

  Panel discussion

  Discussion Period (AU)
• 08:00–08:45 Biogen Corporate Breakfast Symposium on Advancements in Antibody-Mediated Rejection and Microvascular Inflammation of Kidney Allograft
  Parkside 1&2 Industry Symposium

  View Session Details

  Organized by

  
• 08:00–09:30 CMV and BK virus in transplant recipients: Pearls from the guidelines and emerging frontiers
  Room C4.8 Concurrent Infectious Diseases

  View Session Details

  Chairs: Wanessa T. Clemente (BR); Jeremy Chapman (AU)

  Pearls from the BK guidelines

  Nassim Kamar (FR)

  Pearls from the CMV guidelines

  Camille N. Kotton (US)

  Beyond the guidelines- new developments and future directions: BK

  Germaine Wong (AU)

  Beyond the guidelines - new developments and future directions: CMV

  Atul Humar (CA)

  Panel discussion: challenging BK case, challenging CMV case

  Discussion Period (AU)
• 09:15–10:15 Abstract and Concurrent Sessions
  View Session Details

• 09:15–10:15 From allorecognition to allocation: Moving toward more individualized kidney transplant matching
  Room C4.1 Concurrent Histocompatibility

  View Session Details

  Importance of HLA beyond the A/B/DR

  Anat Tambur (US)

  Beyond HLA: Expanding the immunologic landscape

  Toby Coates (AU)

  Precision risk stratification

  Wai Lim (AU)
• 09:15–10:15 Transplantation beyond traditional publications
  Room C4.10 Concurrent

  View Session Details

  Chairs: Stefan Tullius (US); Macey L. Levan (US)

  Special features: A reality check on opportunities and challenges

  Fadi Issa (GB)

  Social media: Are we reaching our audience and readership worldwide

  Jasper Iske (DE)

  Editorial fellowships: A great opportunity to be involved

  Melanie Wyld (AU)

  Topic highlights – Article series

  Camille N. Kotton (US)

  Panel discussion

  Discussion Period (AU)

  Panelist

  Khushboo Saxena (IN)
• 10:15–10:45 Coffee Break / Last chance to visit Exhibit Area
  View Session Details

• 10:15–10:45 Coffee Break
  Hall 1-2 Coffee Break

  View Session Details

• 10:45–12:30 Plenary and Concurrent Sessions / TTS Business Meeting
  View Session Details

• 10:45–12:00 Plenary Session 3
  Darling Harbour Plenary Session

  View Session Details

  Towards transplantable organs: Vascularized kidney organoids for renal regeneration

  Ton J. Rabelink (NL)
• 10:45–12:00 Expanding horizons in pancreas transplantation: Outcomes, techniques, and program development
  Room C4.9 Concurrent Pancreas and Islet

  View Session Details

  Chairs: Pablo Uva (AR); Toby Coates (AU)

  Current status of pancreas transplantation: Activity and outcomes around the world

  Angelika C. Gruessner (US)

  Donation after circulatory death (DCD) in pancreas transplantation: Logistics, use of normothermic regional perfusion (NRP) and outcomes

  Joana Ferrer (ES)

  Future of pancreas transplantation in the landscape of emerging therapies

  Raja Kandaswamy (US)
• 12:00–12:30 TTS Business Meeting
  Darling Harbour Plenary Session

  View Session Details

• 12:30–13:45 Lunch Break / Industry Symposia / Lunch with Experts & Mentors
  View Session Details

• 12:45–13:45 Industry Symposium
  Parkside 1&2 Industry Symposium

  View Session Details

• 12:45–13:30 Lunch and Learn Roundtable
  The Gallery Experts/Mentors

  View Session Details

  Combined liver–kidney transplantation

  Gomathy Narasimhan (IN)

  Designing and strengthening organ donation systems

  Marti Manyalich Vidal (ES)

  Genetic factors influencing transplant outcomes

  Stephen Alexander (AU)

  Clinical Trials in Kidney Transplantation

  Steve J. Chadban (AU)

  From HLA typing to epitope matching

  Lucy Sullivan (AU)

  Encouraging physical activity in transplant recipients with limited endurance or physical limitations

  Liz Schick (CH)

  Roundtable Mentor

  Roslyn B. Mannon (US)

  Roundtable Mentor

  Germaine Wong (AU)

  Roundtable Mentor

  Kate Wyburn (AU)

  Roundtable Mentor

  Medhat Askar (QA)

  Roundtable Mentor

  Macey L. Levan (US)

  Roundtable Mentor

  Henry Pleass (AU)

  TBD related to Uterus Transplant (ethics or donor/recipient selection or pregnancy challenge, etc)

  Mats Brännström (SE)

  Multi-Organ transplantation in children

  Tomoaki Kato (US)
• 13:45–15:15 SOTA, Thematic and Concurrent Sessions
  View Session Details

• 13:45–15:15 Next-Generation Transplantation: Regenerative Medicine Breakthroughs
  Room C4.8 SOTA/Thematic Session Regenerative Medicine/Cell Tx

  View Session Details

  Chairs: Giuseppe Orlando (US); Ekaterine Berishvili-Berney (CH)

  The bioartificial kidney: Lessons learned and the road ahead

  William Fissell (CA)

  Organoids, organs-on-a-chip, and the path to organ manufacturing

  Sean Vincent Murphy (US)

  Artificial heart: A life-saving bridge to transplant

  Francisco Arabia (US)
• 13:45–15:15 Targeted Therapies and Tailored Dosing: The New Era in ABMR Treatment
  Cockle Bay 1 SOTA/Thematic Session Transplant Immunosuppression

  View Session Details

  Chair: Jen Li (AU)

  Is there still a role for anti IL-6R in ABMR treatment?

  Roslyn B. Mannon (US)

  Is anti-CD38 the most promising agent for ABMR?

  Katharina Mayer (AT)

  What does monitoring AUC add compared to C-trough only?

  Teun van Gelder (NL)

  Model Informed precision dosing

  Anders Asberg (NO)
• 13:45–15:15 Clinical Xenotransplantation has Arrived!
  Room C3.3 SOTA/Thematic Session Xenotransplantation

  View Session Details

  Understanding optimal genetic modification

  Peter Cowan (AU)

  Experience and immunosuppression for clinical xenotransplantation

  Raphael Meier (US)

  Molecular analysis in clinical xenotransplantation

  Carmen Lefaucheur (FR)

  Clinical xenotransplantation: A new era through the eyes of patients and families

  Macey L. Levan (US)
• 13:45–15:15 Rise of the Machines: Maximizing donor opportunities in Thoracic Transplantation
  Room C4.4 SOTA/Thematic Session Thoracic

  View Session Details

  Chairs: Miranda Paraskeva (AU); Pablo Sanchez (US)

  Debate 1: Pro normothermic regional perfusion

  Ashish S. Shah (US)

  Debate 1: Pro ex vivo machine perfusion

  Peter MacDonald (AU)

  Debate 2: Pro ex vivo perfusion

  Sandra Lindstedt Ingemansson (SE)

  Debate 2: Pro immediate transplant

  Gregory I. Snell (AU)

  Expanding the donor pool: Practical implementation of normothermic regional perfusion for DCD heart and lung recovery

  Irene Bello Rodriguez (ES)

  Panel Discussion

  Discussion Period (AU)
• 13:45–15:15 State of VCA- Present and Future
  Room C4.7 SOTA/Thematic Session VCA/Uterus

  View Session Details

  Chairs: Patrik Lassus (FI); Hatem Amer (US)

  Overview of VCA transplants

  Hatem Amer (US)

  VCA becoming part of universal health care

  David Leonard (GB)

  Is VCA reconstructive surgery or transplantation

  Linda C. Cendales (US)

  Challenges and opportunities for VCA in the global south

  Subramania Iyer (IN)

  Standardizing outcomes in VCA: Are we ready for a SONG or for COVER

  Allison Jaure (AU)
• 13:45–15:15 Evolving Ethics and Emerging Trends in Transplantation
  Room C4.1 SOTA/Thematic Session Ethics and Transplantation

  View Session Details

  Chairs: David Thomson (ZA); Aviva Goldberg (CA)

  Rating ourselves on the ethics of NRP - How are we doing?

  Anji Wall (US)

  Social media use in transplantation

  Shaifali Sandal (CA)

  Ethical tissue sourcing for organoids: Why and How

  Katrina Bramstedt (CH)

  Pediatric prioritization

  Thozama Siyotula (ZA)

  Retransplantation after nonadherence (adult & children)

  Aaron Wightman (US)
• 13:45–15:15 Evolving strategies in intestinal and multivisceral transplantation
  Room C4.9 SOTA/Thematic Session Liver/Intestine

  View Session Details

  Chairs: Helen Evans (NZ); Rajith Amaratunga (AU)

  Isolated intestine transplantation for short gut syndrome in the era of GLP-2 agonist

  Yaron Avitzur (CA)

  Novel immunosuppression in intestine transplantation

  Jennifer Garcia (US)

  Pros and cons of protocol biopsy and stoma

  Jonathan Hind (AU)
• 13:45–15:15 Diversity, Equity, and Inclusion in Gender and Transplantation
  Room C4.5 SOTA/Thematic Session Equity and Diversity

  View Session Details

  Regional and gender disparities in abstracts presented at international transplant congress

  Maggie Kam Man Ma (HK)

  Unseen and unequal: Addressing gender and financial disparities in access to kidney transplantation

  Elmi Muller (ZA)

  Redefining equity: Women, access, and outcomes in liver transplantation

  Gomathy Narasimhan (IN)

  Designing gender-responsive transplant policies: Lessons from south and southeast Asia

  Yeong Hoon Kim (KR)
• 13:45–15:15 Living Organ Donation in 2026: Unified Principles, Organ-Specific Nuances
  Cockle Bay 2 SOTA/Thematic Session Surgery

  View Session Details

  Shared framework for living donor evaluation: medical, psychosocial, and ethical core

  Krista Lentine (US)

  Surgical challenges and functional outcomes in living kidney donation

  Mireia Musquera (ES)

  Surgical challenges and functional outcomes in living liver donation

  DongJin Joo (KR)

  Predictive models and global registry insights to enhance donor safety

  Allan Massie (US)
• 13:45–15:15 Innovations in skin cancer in transplantation
  Room C3.6 SOTA/Thematic Session Thematic

  View Session Details

  Chairs: Angela Webster (AU); Brenda Maria Rosales (AU)

  Skin cancer risk prediction and communication

  Anne Cust (AU)

  Evaluation of benefits and harms of melanoma screening in chronic disease

  Katy Bell (AU)

  Complex surgical oncology

  Alexander Varey (AU)

  Novel developments in keratinocyte cancer treatments in Australia

  Kiarash Khosrotehrani (AU)

  Panel Discussion

  Discussion Period (AU)
• 13:45–15:15 Pediatric cholestatic liver disease around the world
  Room C3.4-C3.5 Concurrent Pediatric Transplantation

  View Session Details

  Chairs: Gabriel E. Gondolesi (US); Manuel Rodriguez-Davalos (US)

  Biliary atresia - whats happening in Latin America. Access to KPE and transplantation

  Monserrat Arreola Gutierrez (MX)

  Progressive familiar intrahepatic cholestasis differences around the world and the role of medical vs. surgical therapy

  Mohamed Rela (IN)

  Primary sclerosing cholangiotis in children and adolescent

  Michael Stormon (AU)
• 13:45–15:15 Organ donation following MAID (VAD/euthanasia)
  Room C4.11 Concurrent Organ Donation and Critical Care

  View Session Details

  Chair: Helen Opdam (AU)

  Panelist representing Canada

  Matthew Weiss (CA)

  Panelist representing Australia

  Wade Stedman (AU)
• 15:20–16:30 Closing Plenary
  View Session Details

• 15:20–16:30 Closing Plenary
  Darling Harbour Plenary Session

  View Session Details

  Gene and cell therapy in transplantation

  Maria Grazia Roncarolo (US)

  From donor to recipient: Microbiome signatures as predictors of post-transplant complications

  Olivia Smibert (AU)